Deuruxolitinib 8 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 8 mg
Reference Brands: Leqselvi (USA/EU)
Category: Derma Drugs
Deuruxolitinib is an oral Janus kinase (JAK) inhibitor used for the treatment of severe alopecia areata. It works by blocking JAK signaling pathways that drive autoimmune inflammation responsible for hair loss. Leqselvi helps promote hair regrowth in patients with extensive scalp and eyebrow involvement through targeted immune modulation.
Deuruxolitinib — third party manufacturing & bulk supply
Deuruxolitinib 8 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Deuruxolitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Deuruxolitinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Deuruxolitinib is used for treating adults with severe Alopecia Areata, an autoimmune condition where the immune system attacks hair follicles, causing significant hair loss.
Deuruxolitinib is a synthetic small‑molecule Janus kinase (JAK) inhibitor, designed to block JAK1 and JAK2 enzymes to modulate immune signaling.
The trade name of Deuruxolitinib is Leqselvi.
Leqselvi (Deuruxolitinib) is manufactured and marketed by Sun Pharmaceutical Industries.
The generic name is Deuruxolitinib.
The brand name is Leqselvi.
Leqselvi is manufactured by Sun Pharmaceutical Industries.
Related Products
Sofpironium Bromide
Strength:
5%, 12.45%
Form: Topical Gel
Reference Brands: ECCLOCK, Sofdra
View Details
Sarecycline
Strength:
60 mg, 100 mg, 150 mg
Form: Tablets
Reference Brands: Seysara (USA)
View Details
Afamelanotide
Strength:
16 mg
Form: Subcutaneous implant
Reference Brands: Scenesse (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
